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Abstract

Author Manuscript

Objective—Fetal exposure to maternal prenatal stress hormones such as cortisol exerts
influences on the developing nervous system that persist and include risk for internalizing
symptoms later in life. Placental corticotropin-releasing hormone (pCRH) is a feto-placental stress
signal that also shapes fetal neurodevelopment and may be a more direct indicator of the fetal
experience than maternal stress hormones. The programming effects of pCRH on child
development are unknown. The current investigation examined associations between prenatal
maternal and placental stress hormone exposures (maternal cortisol and pCRH) and child selfreported internalizing symptoms at age 5.
Method—Maternal plasma cortisol and pCRH levels were measured at 15, 19, 25, 31, and 36
weeks’ gestation in a sample of 83 women and their 91 children (8 sibling pairs from separate
pregnancies), who were born full-term. Child self-reported internalizing symptoms at age 5 were
obtained using scales of the Berkeley Puppet Interview.
Results—Placental CRH profiles (including elevations in mid-gestation) were associated with
higher levels of internalizing symptoms at age 5. This effect was not explained by critical prenatal
or postnatal influences, including obstetric risk, concurrent maternal psychological state, and
family socio-economic status. Prenatal maternal cortisol was not significantly associated with
child self-reported internalizing symptoms.
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Conclusions—Findings suggest that elevated exposures to the feto-placental stress signal pCRH
exert programming effects on the developing fetal central nervous system, with lasting
consequences for child mental health.
Keywords
fetal programming; prenatal; pregnancy; CRH; cortisol; internalizing problems

1. Introduction

Author Manuscript

The maternal endocrine stress system is profoundly altered during the course of human
pregnancy. The maternal pituitary gland doubles in size, and the synthesis and release of
stress peptides and hormones from the maternal hypothalamic-pituitary-adrenal (HPA) axis
into the maternal circulation increases several-fold. However, it is the growth and
development of a new transient endocrine organ, the placenta, that primarily is responsible
for the profound changes in the maternal and fetal stress systems as gestation progresses. As
early as 7 to 8 weeks’ gestation, the placenta begins to synthesize the stress hormone
corticotropin-releasing hormone (CRH), and this active peptide is released into both the
maternal and fetal circulation (Gitau et al., 2004; Goland et al., 1988; Karteris et al., 2001;
Mastorakos & Ilias, 2003). Placental CRH (pCRH) is identical in structure and activity to
hypothalamic CRH (hCRH) and increases dramatically in the maternal circulation over the
course of human pregnancy, reaching levels only present in the hypothalamic portal system
during stress (Lowry, 1993). Concentrations of circulating maternal CRH are almost
exclusively of placental origin, because the minute quantities of hCRH that are released into
the maternal circulation are rapidly degraded and largely undetectable (Mesiano, 2014).

Author Manuscript
Author Manuscript

The feto-placental unit derives information from maternal physiological signals, including
stress signals conveying a response to environmental threats or challenges, and adapts its
developmental program accordingly (Gluckman & Hanson, 2004; Sandman & Davis, 2012).
Placental CRH is responsive to a range of these stress signals, including increased
norepinephrine and epinephrine, reduced uterine blood flow, and infection (Herrmann et al.,
2001; Petraglia et al., 1989; Wadhwa et al., 2001). Further, in contrast to its negative
feedback regulation of hCRH, maternal cortisol stimulates the synthesis and release of CRH
in the placenta. Placental CRH penetrates the fetal blood-brain barrier and stimulates fetal
adrenal cortisol production, which in turn further stimulates pCRH production (Kastin &
Akerstrom, 2002; Mesiano, 2014). Thus, placental CRH represents an integrative pathway
through which diverse prenatal stressors might inform the fetus of the state of its
environment and shape fetal developmental trajectories (Charil et al., 2010; O’Donnell et al.,
2009; Sandman et al., 2011).
Increasing evidence suggests that anxiety and mood disorders have origins in prenatal
experiences (Baram et al., 2012; Sandman & Davis, 2012). Perhaps one of the most
consistent neurobehavioral findings is that fetal exposure to elevations in stress hormones is
associated with subsequent increased risk for internalizing problems (Bergman et al., 2007;
Davis et al., 2005, 2007; Davis & Sandman, 2012; de Weerth et al., 2003). Most research
examining the role of prenatal stress hormone exposures on the programming of offspring
internalizing symptoms has focused on maternal cortisol, which increases two to four fold
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 May 01.
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over human gestation. Evidence from rodent and non-human primate studies indicates that
fetal exposure to elevated glucocorticoids is associated with increased fearful behavior,
depression-like behavior, and stress reactivity (Abe et al., 2007; Kapoor et al., 2006; Kapoor
& Matthews, 2005; Seckl, 2008). In humans, fetal exposure to elevated concentrations of
maternal cortisol is associated with increased fetal and neonatal reactivity to stimulation
(Davis et al, 2011; Glynn & Sandman, 2012), increased fearful behavior in infancy
(Bergman et al., 2010; Davis et al., 2007; de Weerth et al., 2003), higher levels of
internalizing behavior problems in children (Davis & Sandman, 2012), and alterations in
brain regions association with internalizing problems (Buss et al., 2012; for a review, see
Zijlmans et al., 2015).

Author Manuscript

However, because the placenta is responsive to a variety of stress signals, including cortisol
of both maternal and fetal origin (Mesiano, 2014), levels of circulating pCRH may be a
more direct indicator of fetal exposure and response to stressors than maternal cortisol alone.
In the only published study that evaluated the consequences of pCRH on the development of
internalizing symptoms in humans, elevated pCRH levels at 25 weeks’ gestation predicted
increased mother-reported infant fear and distress (Davis et al., 2005). Further, compelling
evidence from experimental animal models indicates that exposure to stress-induced
elevations in CRH or exogenous CRH early in life may alter the structure and function of
brain regions involved in internalizing symptoms (Avishai-Eliner et al., 2002; Chen et al.,
2010; Maras & Baram, 2012). These findings encourage further investigation of the role of
pCRH in the programming of offspring internalizing symptoms.

Author Manuscript

Mid-gestation is a period of rapid acceleration in maternal cortisol and pCRH trajectories
(Sandman et al., 2006) and appears to be a sensitive window for effects on the fetal central
nervous system (Sandman et al., 2015). Elevations in mid-gestational pCRH are linked to
increased infant fear and distress (Davis et al., 2005), as well as a variety of other fetal and
infant developmental outcomes related to maturation and body composition (Class et al.,
2008; Ellman et al., 2008; Sandman et al., 2006; Stout et al., 2015). The fetal brain is rapidly
developing at mid-gestation, such that it might be particularly susceptible to organizing and
disorganizing programming influences at this time.

Author Manuscript

The aim of the current study is to test the hypothesis that accelerated prenatal trajectories of
pCRH and maternal cortisol during mid-gestation are associated with child self-reported
internalizing symptoms at age 5 in a sample of typically developing children born at full
term. We chose to assess internalizing symptoms early in childhood because rates of
depressive and anxious disorders begin to accelerate at this age (Luby et. al, 2002;
Merikangas et al., 2010), and because early childhood symptoms are predictive of symptom
trajectories and later psychiatric diagnosis (Ialongo et al., 2001). Unlike the vast majority of
studies that have relied on parental report to examine the association between prenatal
exposures and child temperament, we eliminated possible maternal bias and obtained unique
insight into children’s symptoms by directly assessing child self-report of internalizing child
behavior (Ialongo et al., 2001; Luby et al., 2007; Najman et al., 2001).

Psychoneuroendocrinology. Author manuscript; available in PMC 2017 May 01.
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2. Method
2.1 Study Overview
Study participants were mother-child pairs from a prospective, longitudinal study of prenatal
psychobiological risk and development. Women with intrauterine, singleton pregnancies less
than 16 weeks’ gestational age were recruited at a large university medical center in
Southern California and assessed over the course of gestation. Mother-child pairs were
assessed when the child was 5 years of age.
2.2 Participants

Author Manuscript
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The sample comprised 83 mothers and their 91 five-year-old, typically developing children
(Mage = 5.13, 53% female). Eight of these women participated in the study twice for two
separate pregnancies, with both children included in the study1. At recruitment, inclusion
criteria were English-speaking, adult (> 18 years old) women with intrauterine, singleton
pregnancies. Exclusion criteria at recruitment were the presence of uterine or cervical
abnormalities; conditions such as endocrine, hepatic or renal disorders or use of
corticosteroid medication; and self-reported abuse of tobacco, alcohol, or recreational drugs
in pregnancy. Additional inclusion criteria for the current study were delivery of a full-term
infant (gestational age at delivery ≥ 37 weeks; M = 39.64 weeks, SD = 1.14 weeks),
maternal completion of at least 3 of 5 prenatal hormone assessments, and child completion
of the internalizing symptoms scales of the Berkley Puppet Interview. Mothers were
primarily Caucasian, non-Hispanic and Hispanic; had received greater than a high school
level of education; and were cohabiting with the child’s father at the time of child
assessment (see Table 1 for sample descriptives). Mothers provided written informed
consent for all aspects of the protocol, which was approved by the university’s Institutional
Review Board for protection of human subjects.
2.3 Procedures
Maternal blood plasma samples were obtained for cortisol and pCRH analysis at 15 (M =
15.45 ± 0.93), 19 (M = 19.63 ± 1.10), 25 (M = 25.86 ± 1.03), 31 (M = 31.14 ± 0.93), and 36
(M = 36.78 ± 0.87) weeks’ gestation. Obstetric risk information was collected by detailed
medical interviews at each prenatal visit, along with comprehensive examination of prenatal
and delivery medical records. Child self-reported internalizing symptoms and maternal
depressive symptoms were evaluated when children were 5 years of age.
2.4 Measures

Author Manuscript

2.4.1 Endocrine measures—Maternal blood samples (20/ml) were collected by
antecubital venipuncture into EDTA (purple top) vacutainers and then immediately chilled
on ice. Aprotinin (Sigma Chemical, St. Louis, MO) was added at 500 KIU/ml blood.
Samples were centrifuged at 2,000 g for 15 minutes, decanted into polypropylene tubes, and
stored at −80°C until assayed.

1Findings reported here did not change when removing one member of the sibling pair, so both siblings were included in analyses.
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 May 01.

Howland et al.

Page 5

Author Manuscript
Author Manuscript

Total CRH concentrations were determined by a radioimmunoassay with reported sensitivity
of 2.04 pg/ml (RIA; Bachem Peninsula Laboratories, San Carlos, CA). Plasma samples (1–2
ml) were extracted with three volumes of ice-cold methanol, mixed, allowed to stand for 10
minutes at 4°C, and centrifuged at 1700 g and 4°C for 20 minutes (Linton et al., 1995).
Pellets were washed with 0.6 ml methanol, and the combined supernatants were dried down
in a Savant SpeedVac concentrator. Reconstituted samples with assay buffer were incubated
(100 μl/assay tube) with anti-CRH serum (100 μl) for 48 hours at 4°C, followed by a 24hour incubation with 125I-CRH at 4°C. Labeled and unlabeled CRH were collected by
immunoprecipitation with goat antirabbit IgG serum and normal rabbit serum after 90
minutes of incubation at room temperature. Samples were then centrifuged at 1700 g and
4°C for 20 minutes, after which the aspirated pellets were quantified with a gamma
scintillation counter. This assay has less than 0.01% cross-reactivity with ovine CRH, 36%
cross-reactivity with bovine CRH, and nondetectable reactivity with human ACTH. Intraassay and interassay coefficients ranged from 5% to 15%, respectively. For additional
details, see Glynn and Sandman (2014).
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Plasma cortisol levels were determined by a competitive binding solid-phase enzyme-linked
immunosorbent assay with reported sensitivity of 0.22 μg/dl. Plasma samples (20 μl) and
enzyme conjugate (200 μl) were thoroughly mixed in antibody-coated microtiter wells and
incubated at room temperature for 60 minutes. Each well was then washed three times with
wash solution (400 μl per well), followed by a 15-minute incubation at room temperature
with substrate solution (100 μl). Absorbance units were measured at 450 nm within 10
minutes of adding stop solution. This assay has less than 9% cross-reactivity with
progesterone and less than 2% cross-reactivity with other naturally-occurring steroid
hormones (e.g., testosterone, estradiol). Interassay and intra-assay coefficients of variance
were less than 8%.

Author Manuscript

2.4.2 Child self-reported internalizing symptoms—Child self-reported internalizing
symptoms were assessed with the Berkeley Puppet Interview (Measelle et al., 1998), a
validated semi-structured interview designed to measure young children’s perceptions of
their functioning in a variety of academic and socio-emotional domains. The interviewer
engaged the child with two identical hand puppets, which presented the child with
contrasting statements of positive and negative valence, such as, “I’m a happy kid/I’m not a
happy kid.” The child was then asked to indicate which puppet is most like him or her, with
standardized prompts issued only if a response was ambiguous. For the current study,
interviews were conducted by one of three research associates trained and certified in
administration and coding of the BPI by the developers of the measure (Measelle et al.,
1998). Children’s responses were videotaped and later coded independently by two trained
research associates. Each response was rated based on how much emphasis was placed on an
answer, using a seven-point scale ranging from 1 (amplified negative response) to 7
(amplified positive response). Inter-rater reliability across all scales administered was 96%.
For the current investigation, the Depression (7 items), Anxiety (7 items), and Separation
Anxiety (6 items) subscales of the BPI were summed and averaged to create an internalizing
symptoms broadband scale ranging from 1 to 7 (Ringoot et al., 2013). Ratings for each item
were reverse scored; higher total scores on the internalizing symptoms broadband scale
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 May 01.
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reflected higher self-reported internalizing symptoms. Of the 91 children included in
analyses, 4 did not complete 90% or more of the full internalizing symptoms scale. The
subset of items available for these 4 children (ranging from 4 to 11 items) were highly
correlated with the full scale score (r = .79) in the total sample of children and were
considered to be adequately representative of these children’s full scale scores. The
internalizing symptoms broadband scale has previously demonstrated internal reliability and
validity in 5 to 7-year-old children (Ringoot et al., 2013), and reliability in the current
sample was acceptable (α = .73). Further, these internalizing symptom scales have been
found to accurately discriminate between young children with and without a depressive
disorder diagnosis (Luby et al., 2002; 2007) and between community and clinic-referred
children (Ablow et al., 1999).

Author Manuscript

2.4.3 Maternal depressive symptoms—Maternal depressive symptoms were assessed
with the 9-item form of the Center for Epidemiological Studies Depression Inventory
(Santor & Coyne, 1997) when the child was 3 months old and 5 years of age and considered
for potential association with child self-reported internalizing symptoms. Participants
indicated how much they had experienced each symptom in the past week, using a 4-point
Likert scale ranging from 1 (rarely or none of the time) to 4 (most or all of the time). This
measure has been used extensively in previous research and has demonstrated excellent
reliability and validity (Santor & Coyne, 1997). Internal consistency was good in the current
sample (α = .82).

Author Manuscript

2.4.4 Obstetric medical risk—An extensive structured medical interview was performed
by a research nurse at each prenatal visit to assess maternal health and pregnancy-related
complications. Maternal and infant medical records were reviewed to assess pregnancy
complications and birth outcome. The obstetric risk score accounted for prenatal infection,
pregnancy-induced hypertension, gestational diabetes, oligohydramnios, polyhydramnios,
preterm labor, vaginal bleeding, placenta previa, and anemia. A cumulative score assessing
prenatal obstetric risk was derived from the sum of all present risk variables (Hobel, 1982).
In this low risk sample, 71% of women had none of these risk factors, and no woman had
more than two risk factors.
2.5 Statistical Analyses

Author Manuscript

Preliminary analyses included t-tests and correlations to identify demographic (maternal
race/ethnicity, maternal education, maternal cohabitation with child’s father, annual
household income), pregnancy (obstetric medical risk), maternal psychological state
(postpartum and concurrent depressive symptoms), and child (age, sex, birth order) variables
that might be associated with child self-reported internalizing symptoms. Only child sex was
significantly associated with child self-reported internalizing symptoms, with girls reporting
significantly more internalizing symptoms than boys, t(86.30) = 3.07, p = .003.
Multilevel modeling techniques (HLM6; Raudenbush et al., 2004) were conducted to
evaluate associations between prenatal hormone trajectories and child self-reported
internalizing symptoms. Multilevel modeling is advantageous in the case of repeated
measures data, because it allows for hierarchical modeling of both within-dyad (prenatal
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Howland et al.

Page 7

Author Manuscript

hormone levels) and between-dyad (child self-reported internalizing symptoms) variance.
Multilevel models produce robust estimates of missing values for the repeated measure.
Models weight cases with complete data more heavily, but all cases are included in the
estimation of effects. In the current sample, every woman completed at least 3 of 5 prenatal
hormone assessments, with 44 women completing all 5 assessments. Women with
incomplete prenatal hormone data were not significantly different from women with
complete data on any demographic, maternal psychological state, or child variables. These
women also did not significantly differ in prenatal hormone trajectories or child selfreported internalizing symptoms.

Author Manuscript

Initial testing indicated that a quadratic model best fit maternal plasma cortisol trajectories,
and a cubic model best fit pCRH trajectories. For each prenatal hormone, a series of twolevel models were computed to test differences in level (intercept) and instantaneous rate of
change (slope) at 1-week intervals within the range of assessments available (13 – 39 weeks’
gestation). Positive differences in the instantaneous rate of change or slope reflected
acceleration in the prenatal hormone trajectory at the interval tested. In each two-level
model, level 1 (time-variant, within-dyad) variables were hormone levels at each study visit
and the timing of these visits in gestational weeks. For cortisol analyses, time of sample
collection was also added as a level 1 variable in all models (pCRH was not related to time
of sample collection). Child self-reported internalizing symptoms and child sex were
included as level 2 (time-invariant, between-dyad) variables in each model.

3. Results
3.1 Descriptives

Author Manuscript

As expected, a repeated measures ANOVA indicated that significant increases in maternal
plasma levels of pCRH, F(1.71, 73.42) = 356.08, p < .001, and cortisol, F(3.56, 266.62)
=118.56, p < .001, were observed over the course of pregnancy. After adjusting for
gestational age and time at sample collection, concurrent pCRH and cortisol levels were
significantly correlated only at the 36 weeks’ gestation assessment, r = .25, p = .02,
consistent with data from previous examinations (Magiakou et al., 1996; Sandman et al.,
2006). Placental CRH, F(1.74, 71.27) = 0.71, p = .48, and cortisol, F(3.57, 260.39) = 0.39, p
= .79, trajectories did not differ by fetal sex. Children reported relatively low levels of
internalizing symptoms, with scores ranging from 2.00 – 5.20 (M = 3.01 ± 0.70).
3.2 Associations with child self-reported internalizing symptoms

Author Manuscript

Because child sex was significantly associated with child self-reported internalizing
symptoms, we initially included it as a covariate in all models tested. Child sex was not a
significant level-2 variable at any of the gestational intervals tested for either prenatal
hormone. Further, child sex was not a moderating variable; the magnitude and direction of
associations were the same when testing the models separately for male and female children.
Therefore, we did not adjust for child sex in the final models reported here. Profiles of
placental CRH over gestation were associated with child self-reported internalizing
symptoms (see Figure 1). Fetal exposure to an acceleration (instantaneous rate of change) in
pCRH at 22–23 gestational weeks was associated with higher child internalizing symptoms
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(Coefficients: 3.04–3.47, SE = 1.51–1.72, ps < .05). This acceleration in placental CRH
production resulted in exposure to higher levels of pCRH at 27–28 gestational weeks
(Coefficients: 25.76–28.72, SE = 12.79–14.44, ps < .05), such that a 25.75–28.70 pg/ml
increase in pCRH was associated with a 1unit increase in child self-reported internalizing
symptoms. These data suggest that elevated fetal exposures to pCRH at mid-gestation
represents a risk factor for increased internalizing symptoms in early childhood.
Prenatal plasma cortisol trajectories were not related to self-reported internalizing symptoms
in 5 year-old children, with no differences in slope (Coefficients: −0.12–0.08, SE = 0.05–
0.22, ps > .10) or level (Coefficients: −1.07–0.15, SE = 0.56–1.42, ps > .10) at any
gestational period.

4. Discussion
Author Manuscript
Author Manuscript

The current study provides evidence that pCRH, a stress signal of feto-placental origin, may
be a pathway through which fetal programming influences risk for child internalizing
symptoms. This prospective, longitudinal study in a unique cohort of children documents
that fetal exposure to accelerated pCRH trajectories during mid-gestation is associated with
child internalizing symptoms at 5 years of age. This effect was not explained by postnatal or
other prenatal influences, including obstetric risk, postpartum or concurrent maternal
psychological state, or family socio-economic status. Furthermore, this investigation
included only children born full-term, so the consequences of prenatal pCRH exposures
were independent of the well-documented effects of pCRH on preterm birth (Sandman et al.,
2006; Smith et al., 2009) and of preterm birth on child internalizing symptoms (Bhutta et al.,
2002). The association between increased pCRH and higher child self-reported internalizing
symptoms is consistent with experimental animal research demonstrating that prenatal
exogenous CRH exposure is linked to increased anxiety behaviors in offspring (Williams et
al., 1995) and with human research linking elevated pCRH to altered profiles of fetal
neurodevelopment (Class et al., 2008; Ellman et al., 2008) and increased infant fear and
distress (Davis et al., 2005).

Author Manuscript

Contrary to previous examinations that have relied on maternal report or laboratory
observations of child behavior (Bergman et al., 2010; Bergman et al., 2007; Davis et al.,
2007; Davis et al., 2011; Davis & Sandman, 2012; de Weerth et al., 2003), we did not
observe an association between prenatal maternal cortisol and child internalizing symptoms.
This may be related to differences between assessments of emotional and social adjustment
from parental report and those determined directly from the child. In a large validation study
of the child self-report measure of internalizing symptoms utilized in the current study, the
child-report scale was weakly correlated with a parent-report measure of child internalizing
symptoms, with the two scales sharing only 3% of their variance (Ringoot et al., 2013).
While parent and child perspectives of children’s internalizing symptoms are clearly
different, evidence suggests that both informants provide reliable and valid information in
the characterization of these symptoms (Ablow et al., 1999; Ialongo et al., 2001; Jensen et
al., 1999; Luby et al., 2002, 2007). We suggest that placental CRH exposures may explain a
different, unique portion of variance in children’s internalizing symptoms, compared with
the variance in symptoms that can be explained by prenatal maternal cortisol exposures.

Psychoneuroendocrinology. Author manuscript; available in PMC 2017 May 01.
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Indeed, the current study suggests that the aspects of children’s internalizing symptoms
associated with pCRH exposures and not with maternal cortisol exposures are specifically
those aspects captured by child report. Distinct physiological mechanisms may also be at
play. For instance, exogenous CRH exposures in early-life have been shown to induce
depression-like behavioral deficits in rats for which plasma glucocorticoids were clamped at
low levels, indicating that CRH has programming effects independent of the effects of
cortisol exposures (Brunson et al., 2001; Maras & Baram, 2012).

Author Manuscript

The rapid increase in pCRH during mid-gestation (Sandman et al., 2006) coincides with
major developmental advances in the fetal nervous system, which may render the fetus
particularly vulnerable at this time (de Graaf-Peters & Hadders-Algra, 2006; Sandman et al.,
2015). By 28 weeks’ gestation, neuronal proliferation is 40% greater than in the adult brain
(Becker et al., 1984; Bourgeois et al., 1994; Huttenlocher & Dabholkar, 1997). Cortical
synapse formation accelerates between 24–26 weeks’ gestation, resulting in a six-fold
increase in synaptic density from 28 weeks onward (de Graaf-Peters & Hadders-Algra,
2006; Levitt, 2003). Apoptosis also peaks at this time, which plays a fundamental role in
determining the final number of neurons and glial cells present in the brain (de Graaf-Peters
& Hadders-Algra, 2006).
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Fetal exposure to elevated pCRH may confer risk for internalizing symptoms by
programming of fetal brain regions and/or the fetal HPA axis. CRH is released from the
placenta into fetal circulation and penetrates the immature fetal blood-brain barrier (Kastin
& Akerstrom, 2002), where it may alter the trajectories of developing structures.
Differentiated cortical neurons in the fetal brain express CRH receptors as early as 13
weeks’ gestation. Elevations in pCRH may regulate neurogenesis, synaptogenesis and
apoptosis (Koutmani et al., 2013) specifically in CRH receptor-rich limbic regions linked to
fear, anxiety, and depression, such as the amygdala and hippocampus (Avishai-Eliner et al.,
2002; Charil et al., 2010; Cratty et al., 1995; Schumann et al., 2011). Rats exposed to
exogenous CRH in the early postnatal period have been shown to exhibit progressive
hippocampal cell loss and learning and memory dysfunctions distinctive to depression
(Brunson et al., 2001). Additionally, hormone activity can be detected in the fetal HPA axis
as early as 8–12 weeks’ gestation, with CRH regulating the growth of pituitary
corticotrophs, adrenocortical differentiation, and steroidogenic maturation of the fetal HPA
axis (Mesiano & Jaffe, 1997; Ng, 2000). The set points of the progressively activated fetal
HPA axis may be permanently altered by increased pCRH in the fetal circulation (Goland et
al., 1988; Mastorakos & Ilias, 2003; Petraglia et al., 1989; Sandman et al., 2011).
4.1 Limitations
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The current study examined naturally occurring variations in prenatal stress hormone
signals; without experimental manipulation, we cannot confirm independent effects of
pCRH beyond other potential contributing factors such as genetic vulnerability. Notably, the
effect observed in this study was not explained by maternal depressive symptomology at the
time of child assessment. Additionally, our findings are consistent with experimental animal
studies linking prenatal and early postnatal CRH exposures to offspring distress and
depression-like dysfunction in which random assignment was possible (Brunson et al., 2001;
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Williams et al., 1995). Results of human studies involving children conceived by in vitro
fertilization and not genetically related to their mothers also provide evidence that prenatal
exposures are linked with negative child mental health outcomes, including internalizing
symptomology (Rice et al., 2010). In addition, maternal cortisol levels were assessed at only
one time during the day at each of the five assessment intervals, so we did not account for
individual differences in diurnal variation of cortisol levels. However, we did adjust for time
of day when modeling maternal cortisol trajectories across gestation.
4.2 Implications

Author Manuscript

Results of the current investigation are consistent with previous studies demonstrating the
effects of prenatal stress on fetal central nervous system development. Placental CRH is a
feto-placental signal independently responsive to a number of major stress signals and
represents a plausible biological mechanism of prenatal programming of risk for anxiety and
depression later in life. We assessed internalizing problems using child report, and there is
some evidence that these reports may be more predictive than parent-report of later
emergence of clinical levels of depression and anxiety (Ialongo et al., 2001; Luby et al.,
2007). Further, our finding was observed in a sample of healthy, low-risk mother-child pairs,
and thus it is possible that more extreme effects would be observed in higher risk
populations.

Author Manuscript

The fetal period is a particularly sensitive window of development. The fetal central nervous
system is in a state of unmatched growth and neuroplasticity, and the structure, function, and
set-points of neural circuitry are primarily calibrated at this time. The fetal programming
model of development (Barker, 1998) proposes that fetal exposures to signals of adversity
such as pCRH are associated with later risk for disease. Our finding of increased
internalizing symptoms in children with fetal exposure to elevated pCRH may support the
programming model, because young children’s internalizing symptoms are predictive of
psychiatric diagnosis in adolescence and adulthood (Copeland et al., 2013; Gregory et al.,
2005; Ialongo et al., 2001; Roza et al., 2003). However, it also is possible that these effects
represent an adaptive response in preparation for life after birth. It can be argued that fetal
exposure to signals of adversity results in neurodevelopmental adjustments to prepare for a
postnatal environment predicted to be hostile or threatening (Gluckman & Hanson, 2004).
Internalizing symptoms could then reflect a survival strategy of increased vigilance in the
face of threat or withdrawal from threat in an effort to conserve resources (Copeland et al.,
2013; Gregory et al., 2005; Ialongo et al., 2001; Roza et al., 2003). Follow-up of the current
study’s cohort into adolescence will allow for continued examination of the potentially longterm effects of pCRH exposures.
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Highlights
•

The feto-placental stress hormone pCRH is responsive to a variety of major
stress signals and may be a direct indicator of fetal exposure to prenatal stress.

•

This prospective, longitudinal study documents an association between fetal
exposure to pCRH and child self-reported internalizing symptoms at age 5.

•

pCRH is a plausible pathway of risk for prenatal programming of childhood
internalizing symptoms.
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Figure 1.
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Fetal exposure to trajectories of placental CRH is associated with child report of
internalizing symptoms at age 5. Child internalizing symptom scores were treated as a
continuous variable for analyses. Trajectories of exposure to placental CRH for children
with internalizing symptom scores above or below 1 standard deviation are plotted for
illustrative purposes. Inset illustrates gestational window at which acceleration and level of
placental CRH concentrations are positively associated with child internalizing symptoms.

Author Manuscript
Psychoneuroendocrinology. Author manuscript; available in PMC 2017 May 01.

Howland et al.

Page 18

Table 1

Author Manuscript

Participant Characteristics at Child Assessment (N = 91 children)
M

SD

Maternal age

35.3

5.2

Child age

5.1

0.2

87,746.3

55,675.5

N

%

48

52.7

46

50.5

Caucasian, non-Hispanic

47

51.6

Latina

22

24.2

Asian

9

9.9

Other

13

14.3

Annual household income (USD) 87,746.3

Child sex
Female
Child birth order
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First born
Maternal race

Maternal education
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High school or less

9

9.9

Associates or vocational degree

29

31.9

4-year college degree

29

31.9

Graduate degree

15

16.5

Yes

75

82.4

No

16

17.6

Maternal cohabitation with child’s father
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